A cyberattack has led to an extortion attempt against Novo Nordisk, a global leader in diabetes care. The hacking group has demanded a ransom following the breach, signaling a serious threat to the company’s operations and data security.
The incident raises concerns about the vulnerabilities within the pharmaceutical industry, especially as cyber threats continue to evolve. Novo Nordisk is now faced with the challenge of mitigating potential damages and safeguarding sensitive information.
Details regarding the specific demands made by the hackers have not been disclosed, but the situation underscores the increasing risks companies face in the digital landscape.